CN103709191A - Synthetic method of acotiamide hydrochloride hydrate - Google Patents
Synthetic method of acotiamide hydrochloride hydrate Download PDFInfo
- Publication number
- CN103709191A CN103709191A CN201410024859.6A CN201410024859A CN103709191A CN 103709191 A CN103709191 A CN 103709191A CN 201410024859 A CN201410024859 A CN 201410024859A CN 103709191 A CN103709191 A CN 103709191A
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- compound shown
- amine
- synthetic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
Abstract
The invention relates to a synthetic method of acotiamide hydrochloride hydrate. The synthetic route is as follows: hydroxyl at ortho position of the carboxyl in a compound shown in formula (1) is protected to obtain a compound shown in formula (2), the compound shown in formula (2) is subjected to acylating chlorination to obtain a compound shown in the formula (3), the compound shown in the formula (3) and a compound shown in the formula (4) are subjected to condensation to obtain a compound shown in the formula (5), the compound shown in the formula (5) and a compound shown in the formula (6) are subjected to condensation to obtain a compound shown in the formula (7), the hydroxyl at the second position of a benzene ring of the compound shown in the formula (7) is removed, and then salt forming is carried out to obtain the acotiamide hydrochloride hydrate. The synthetic method has the beneficial effects that the compound shown in formula (2) can be directly used for next-step reaction without extraction to form the compound shown in the formula (5) with a one-pot method, the method has high selectivity, less side reaction and high yield, the compound shown in the formula (5) can be prepared into a compound shown in the formula (8) with the one-pot method, the deprotection selectivity is high, the side reaction is less, the operating steps are less and industrialization can be realized easily.
Description
Technical field
The invention belongs to chemical field, relate in particular to technical field of organic synthesis, be specifically related to a kind of hydrochloric acid Ah examining for the synthetic method of amine.
Background technology
Hydrochloric acid Ah examining is for amine Acotiamide hydrochloride, and chemical name is: N-[2-(diisopropylaminoethyl) ethyl]-2-[(2-hydroxyl-4,5-dimethoxy benzoyl) amino]-1,3-thiazoles-4-carboxamide hydrochloride, structure is as follows:
Hydrochloric acid Ah examining is the acetylcholinesterase depressant class stomach motility enhancing medicine of Japanese Zeria Pharmaceutical company and Astellas joint development for amine, treat functional dyspepsia medicine, that first of whole world approval is specifically designed to the medicine for the treatment of FD, in June, 2013, commodity were called Acofide in Japanese Initial Public Offering.Functional dyspepsia (Functional dyspepsia, FD) refers to that one group of common symptom comprises Abdeminal pain, early full, burning sensation, belch, nausea and vomiting and inenarrable epigastric discomfort sense etc., and without definite organic disease.In default of organic disease basis, uncomfortable and impact that may be on quality of life that the harm that functional dyspepsia brings to patient embodies a concentrated expression of that digestive symptoms causes.Some patients were, because functional dyspepsia symptom causes feed to be reduced, digest and assimilate Efficiency Decreasing, causes malnutrition (comprising that nutritive ingredient is not comprehensive) in various degree.Along with the raising that people require and functional dyspepsia is familiar with quality of life, the medical number of this disease is increasing gradually, becomes the modal disease partner of Digestive System Department and waits one of group.High morbidity like this, for functional dyspepsia medicine provides huge market.
The synthetic method of having reported is at present less, is mainly divided into four kinds of methods, is described below respectively:
Method 1, with reference to CN1084739C, synthetic route is as follows.The weak point of this patent is: (1) use sulfur oxychloride and ethylene dichloride toxicity large, environment is had to destructive material; (2) demethylation yield lower (bibliographical information is 64.6%-86%).In this patent example, report that the first step and second step total recovery are that after 84.6%, the three-step reaction and recrystallization, total recovery is 61%, total recovery is 51.6%.
Method 2, the 25th page of the preparation method A(reporting in patent CN1063442C) report (reference example 1 and 6 is not mentioned its universal method).Patent CN102030654B(page 3) in, mention: second step demethylation reaction can produce a lot of by products, be difficult to optionally only take off the protecting group of 2-hydroxyl, poor selectivity.Concrete synthetic example is as follows:
The preparation method B(mentioning in method 3 patent CN1063442C does not protect preparation method, the 25th page), wherein the yield of two-step reaction is all very low.Ah examining be for the above example (example 38) of preparation method's reference of amine, specifically prepare in the yield literary composition of Ah examining for amine not mentioned, if but adopt the primary amino of above method starting material that side reaction can occur.Concrete synthetic example is as follows:
Report method in method 4 patent CN101006040B.The first step demethylation can also be used titanium tetrachloride and aluminum chloride; Second step reaction can be used phenol/sulfur oxychloride.Yield and purity all higher (total recovery is 73%) in synthetic route.
Though the method for reporting in synthetic method 3 patent CN1063442C in above method is not suitable for synthetic for amine of Ah examining, and can improve on this basis.
In above-mentioned patent, CN1084739 reaction reagent adopts ethylene dichloride, and toxicity is large, and environment is had to destructiveness, and overall yield of reaction is low, is unfavorable for suitability for industrialized production; The second step demethylation reaction of mentioning in patent CN102030654B can produce a lot of by products, is difficult to optionally only take off the protecting group of 2-hydroxyl, and reaction preference is poor, and side reaction is more.
Summary of the invention
The object of this invention is to provide a kind of hydrochloric acid Ah examining for the synthetic method of amine; overcome above-mentioned technical deficiency part; 2 hydroxyls are protected and deprotection; preparation formula (8) compound; reduce side reaction; improve reaction yield, reduce production costs, be provided as the preparation method of the useful 2-Hydroxylbenzamide derivative of pharmaceuticals.
The object of the invention is to be achieved through the following technical solutions:
Hydrochloric acid Ah examining is for a synthetic method for amine, and its synthetic route is as follows:
Synthesis step is as follows:
1) hydroxyl protection at formula (1) compound carboxyl ortho position is obtained to formula (2) compound,
2) formula (2) compound obtains formula (3) compound through chloride,
3) formula (3) compound and formula (4) compound condensation obtain formula (5) compound;
4) formula (5) compound and formula (6) compound condensation obtain formula (7) compound,
5) formula (7) compound is sloughed the protection of phenyl ring (2) position hydroxyl, and salify obtains hydrochloric acid Ah examining for amine;
Wherein R is hydroxy-protective group; can be: TMS, triethyl silyl, tertiary butyl methyl-monosilane base, tri isopropyl silane base, tert-butyl diphenyl silylation, tertiary butyl dimethylsilyl, pentanoyl, benzoyl, ethanoyl, tertbutyloxycarbonyl, preferred tertiary butyl dimethylsilyl, tertbutyloxycarbonyl.
The preferred step of method of the present invention is as follows:
Step 1:2-[N-(2-tertbutyloxycarbonyl-4,5-dimethoxy benzoyl) amino] preparation of-4-methoxycarbonyl-1,3-thiazoles (formula (5) compound)
By 2-hydroxyl-4,5-dimethoxybenzoic acid obtains formula (2) compound with hydroxyl protection reagent react in organic solvent; Formula (2) compound and sulfur oxychloride react in DMF, and products therefrom further reacts with 2-amino-4-methoxyl carbonyl-1,3-thiazoles, obtain formula (5) compound;
Step 2:2-[N-(2-hydroxyl-4,5-dimethoxy benzoyl) amino]-4-[(2-diisopropylaminoethyl ethyl) aminocarboxyl] preparation of-1,3-thiazoles hydrochloride (formula (7) compound)
By formula (5) compound and N, N-diisopropyl ethylenediamine reacts in N,N-dimethylacetamide, and products therefrom passes into hydrogen chloride gas in solvent, and collecting precipitation thing obtains formula (7) compound.
Due to 2-tertbutyloxycarbonyl-4, it is again a new compound that 5-dimethoxybenzoic acid (formula (2) compound) plays an important role simultaneously in reaction, and for this reason, the present invention also provides the preparation of formula (2) compound as a new compound.
Formula (2) compounds process for production thereof is as follows:
By 2-hydroxyl-4,5-dimethoxybenzoic acid is dissolved in dry toluene, adds hydroxyl protection reagent react 1-5 hour under room temperature, first with acid solution washing, then washes with water to neutrality, adds desiccant dryness, filters, and concentrating filter liquor is drying to obtain.
The spectroscopic data of relevant formula (2) compound is as follows:
2-tertiary butyl dimethyl-silicon alcoxyl base-4,5-dimethoxybenzoic acid (2a)
H1-NMR(DMSO,400MHz)δ:0.08(s,3H,-SiCH3),0.09(s,3H,-SiCH3),0.14(s,3H,-CH3);0.22(s,3H,-CH3),0.35(s,3H,-CH3),4.59(s,3H,-OCH3),4.68(s,3H,-OCH3),7.26(s,1H,ArH)，7.63(s,1H,ArH)，11.27(s,1H,-COOH)。
2-tertbutyloxycarbonyl-4,5-dimethoxybenzoic acid (2b)
H1-NMR(DMSO,400MHz)δ:1.34（s,3H）,1.37（s,3H）,1.40（s,3H），3.77(s,3H),3.82(s,3H),7.17(s,1H),7.50(s,1H),13.45～13.70(bs,1H)
Method of the present invention, can without extraction, be directly used in next step reaction and form one kettle way preparation formula (5) compound formula (2) compound, simultaneously for also can use one kettle way to prepare from formula (5) compound to formula (7) compound, thereby reduced operation steps.
As available new compound, the present invention also can feed intake formula 2 compounds as starting raw material, more simplified operation, and relevant step can be as follows:
Formula 2 compounds and 2-amino-4-methoxyl carbonyl-1,3-thiazoles reaction 5 hours, after reaction finishes, filters and collects crystal, further and N, N-diisopropyl ethylenediamine reaction 8 hours, passes into hydrogen chloride gas to this crystal, filter collecting precipitation thing, through recrystallization, obtain hydrochloric acid Ah examining for amine.
Beneficial effect of the present invention is: formula (2) compound is directly used in next step reaction without extraction and forms one kettle way preparation formula (5) compound; selectivity is high, side reaction is few, yield is high; simultaneously for also can use one kettle way preparation from formula (5) compound to formula (8) compound; deprotection selectivity is high, side reaction is few, operation steps is few, is easy to realize industrialization.
Embodiment
By the following examples, can conduct further description the present invention, yet scope of the present invention is not confined to following embodiment.
Embodiment 1
2-tertiary butyl dimethyl-silicon alcoxyl base-4,5-dimethoxybenzoic acid (2a) synthetic
By 2-hydroxyl-4,5-dimethoxybenzoic acid (100 grams) is dissolved in dry toluene (400 milliliters), under room temperature, in solution, slowly add TBSOTf(160 gram) stir 5 hours, add purified water washing to neutral, get organic phase, add anhydrous sodium sulphate (20 grams) dry 8 hours, filter, evaporated under reduced pressure obtains 134 grams of title compounds, yield 85%, fusing point: 235 ℃
H1-NMR(DMSO,400MHz)δ:0.08(s,3H,-SiCH3),0.09(s,3H,-SiCH3),0.14(s,3H,-CH3);0.22(s,3H,-CH3),0.35(s,3H,-CH3),4.59(s,3H,-CH3),4.68(s,1H,-CH3),7.26(s,1H,ArH))，7.63(s,1H,ArH)，8.24(s,1H,Ar11.27(s,1H,CONCOOH)。
Embodiment 2
2-tertbutyloxycarbonyl-4,5-dimethoxybenzoic acid (2b) synthetic
By 2-hydroxyl-4,5-dimethoxybenzoic acid (100 grams) is dissolved in dry toluene (400 milliliters), under room temperature, add Boc2O(132 gram) stirring at room 3 hours, add 10% aqueous citric acid solution (100 milliliters) washing three times, purified water is washed till neutrality, adds anhydrous sodium sulphate (20 grams) dry 8 hours, filter, evaporated under reduced pressure obtains title compound (135 grams), yield 90%, fusing point: 190 ℃
H1-NMR(DMSO,400MHz)δ:1.34（s,3H）,1.37（s,3H）,1.40（s,3H），3.77(s,3H),3.82(s,3H),7.17(s,1H),7.50(s,1H),13.45-13.70(bs,1H)。
Embodiment 3
Step 1:2-[N-(2-tertiary butyl dimethyl-silicon alcoxyl base-4,5-dimethoxy benzoyl) amino] preparation of-4-methoxycarbonyl-1,3-thiazoles
By 2-hydroxyl-4, 5-dimethoxybenzoic acid (100 grams) is dissolved in dry toluene (400 milliliters), under room temperature, in solution, slowly add TBSOTf(160 gram) stir 5 hours, add purified water washing to neutral, get organic phase, add anhydrous sodium sulphate (20 grams) dry 8 hours, filter, in filtrate, add sulfur oxychloride (60 grams) and N, dinethylformamide (0.18 milliliter), at 80 ℃, stir 4 hours, in compound, add 2-amino-4-methoxyl carbonyl-1, 3-thiazole (80 grams), at 100 ℃, stir 5 hours, after reaction finishes, be cooled to room temperature, leaching crystallize out, crystal joins in 1.6 premium on currency, add 400 grams of ice to stir, and to add mass ratio be 10% aqueous sodium hydroxide solution, regulate aqueous solution pH to 7.5, stirring at room is 3 hours subsequently, filter and collect crystal, washing, 60 ℃ are dried to obtain title compound (155 grams).
H1-NMR(DMSO,400MHz)δ:0.08(s,3H,-SiCH3),0.09(s,3H,-SiCH3),0.14(s,3H,-CH3);0.22(s,3H,-CH3),0.35(s,3H,-CH3),4.59(s,3H,-CH3),4.68(s,1H,-CH3),4.83(s,1H,-CH3),7.26(s,1H,ArH),7.63(s,1H,ArH),8.24(s,1H,ArH),11.27(s,1H,CONH)。
Step 2:2-[N-(2-hydroxyl-4,5-dimethoxy benzoyl) amino]-4-[(2-diisopropylaminoethyl ethyl)-aminocarboxyl] preparation of-1,3-thiazoles hydrochloride
By 2-[N-(2-tertiary butyl dimethyl-silicon alcoxyl base-4, 5-dimethoxy benzoyl) amino]-4-methoxycarbonyl-1, 3-thiazole (150 grams) and N, N-diisopropyl ethylenediamine (137 milliliters), N, N-N,N-DIMETHYLACETAMIDE (137 milliliters), at 135 ℃, stir 8 hours, cooling, add propyl carbinol (1.5 liters), aqueous sodium hydroxide solution and saturated common salt water washing with 0.5N, concentrating under reduced pressure mixture, add methyl alcohol (1.5 liters), under cooling, pass into hydrogen chloride gas, stir 5 hours, filter collecting precipitation thing, crystal is done to recrystallization with the mixed solvent of Virahol and water, obtain title compound.Fusing point: 160 ℃
H1-NMR(DMSO,400MHz)δ:1.33(d,J=6.4Hz,6H);1.36(d,J=6.4,6H),3.17-3.20(m,2H);3.57-3.69(m,4H),3.77(s,3H),3.82(s,3H),6.89(s,1H),7.50(s,1H),7.91(s,1H);8.74(t,1H,J=5.9Hz);9.70(s,1H);11.80(s,1H);12.05-12.15(bs,1H)。
Embodiment 4
Step 1:2-[N-(2-tertbutyloxycarbonyl-4,5-dimethoxy benzoyl) amino] preparation of-4-methoxycarbonyl-1,3-thiazoles
By 2-hydroxyl-4, 5-dimethoxybenzoic acid (100 grams) is dissolved in dry toluene (400 milliliters), under room temperature, add Boc2O(132 gram) stirring at room 3 hours, add 10% aqueous citric acid solution (100 milliliters) washing three times, purified water is washed till neutrality, add anhydrous sodium sulphate (20 grams) dry 8 hours, filter, in filtrate, add sulfur oxychloride (64 grams) and N, N dimethyl formamide (0.19 milliliter), at 80 ℃, stir 4 hours, in compound, add 2-amino-4-methoxyl carbonyl-1, 3-thiazole (85 grams), at 100 ℃, stir 5 hours, after reaction finishes, be cooled to room temperature, leaching crystallize out, crystal joins in 1.6 premium on currency, add 400 grams of ice to stir, and to add mass ratio be 10% aqueous sodium hydroxide solution, regulate aqueous solution pH to 7.5, stirring at room is 3 hours subsequently, filter and collect crystal, washing, 60 ℃ are dried to obtain title compound (170 grams).
H1-NMR(DMSO,400MHz)δ:1.34（s,3H）,1.37（s,3H）,1.40（s,3H），3.77(s,3H),3.82(s,3H),3.88(s,3H),7.17(s,1H),7.50(s,1H),7.95(s,1H),11.45(bs,1H)。
Step 2:2-[N-(2-hydroxyl-4,5-dimethoxy benzoyl) amino]-4-[(2-diisopropylaminoethyl ethyl)-aminocarboxyl] preparation of-1,3-thiazoles hydrochloride
By 2-[N-(2-tertbutyloxycarbonyl-4, 5-dimethoxy benzoyl) amino]-4-methoxycarbonyl-1, the preparation of 3-thiazole (170 grams) and N, N-diisopropyl ethylenediamine (162 milliliters), N, N-N,N-DIMETHYLACETAMIDE (162 milliliters), at 135 ℃, stir 8 hours, cooling, add n-butyl alcohol (1.7 liters), aqueous sodium hydroxide solution and saturated common salt water washing with 0.5N, concentrating under reduced pressure mixture, add methyl alcohol (1.7 liters), under cooling, pass into hydrogen chloride gas, stir 5 hours, filter collecting precipitation thing, crystal is done to recrystallization with the mixed solvent of 2-propyl alcohol and water, obtain title compound.Fusing point: 160 ℃.
H1-NMR(DMSO,400MHz)δ:1.33(d,J=6.4Hz,6H);1.36(d,J=6.4,6H),3.17-3.20(m,2H);3.57-3.69(m,4H),3.77(s,3H),3.82(s,3H),6.89(s,1H),7.50(s,1H),7.91(s,1H);8.74(t,1H,J=5.9Hz);9.70(s,1H);11.80(s,1H);12.05-12.15(bs,1H)。
For further illustrating advantage of the present invention, below by experiment data proved:
The present invention is not limited to above-mentioned preferred forms; anyone can draw other various forms of products under enlightenment of the present invention; no matter but do any variation in its shape or structure; every have identical with a application or akin technical scheme, within all dropping on protection scope of the present invention.
Claims (9)
1. formula (2) compound,
Wherein, R is TMS, triethyl silyl, tertiary butyl methyl-monosilane base, tri isopropyl silane base, tert-butyl diphenyl silylation, tertiary butyl dimethylsilyl, pentanoyl, benzoyl, ethanoyl or tertbutyloxycarbonyl.
2. the preparation method of formula claimed in claim 1 (2) compound; it is characterized in that; comprise the following steps: by 2-hydroxyl-4; 5-dimethoxybenzoic acid is dissolved in dry toluene, adds hydroxyl protection reagent react 1-5 hour under room temperature, first with acid solution, washs; wash with water again to neutrality; add desiccant dryness, filter, concentrating filter liquor is drying to obtain.
3. hydrochloric acid Ah examining, for a synthetic method for amine, is characterized in that, comprises the following steps:
1), make formula (1) compound react and obtain formula (2) compound under organic solvent and hydroxyl protection reagent condition;
2), formula (2) compound obtains formula (3) compound through chloride;
3), formula (3) compound reacts the formula of obtaining (5) compound with formula (4) compound;
4), formula (5) compound reacts the formula of obtaining (7) compound with formula (6) compound; And
5), the protection of sloughing 2 hydroxyls of phenyl ring of formula (7) compound, salify obtains formula (8) hydrochloric acid Ah examining for amine;
Wherein, in formula (2), formula (3), formula (5) and formula (7) compound, R is TMS, triethyl silyl, tertiary butyl methyl-monosilane base, tri isopropyl silane base, tert-butyl diphenyl silylation, tertiary butyl dimethylsilyl, pentanoyl, benzoyl, ethanoyl or tertbutyloxycarbonyl.
4. hydrochloric acid Ah examining according to claim 3, for the synthetic method of amine, is characterized in that: in step 1), organic solvent is polarity organic reagent or nonpolar organic reagent.
5. hydrochloric acid Ah examining according to claim 4, for the synthetic method of amine, is characterized in that: described polarity organic reagent is acetonitrile or methylene dichloride, and described nonpolar organic reagent is toluene.
6. hydrochloric acid Ah examining according to claim 3, for the synthetic method of amine, is characterized in that: in step 1), hydroxyl protection reagent is silylation reagent, acylting agent and tert-Butyl dicarbonate.
7. hydrochloric acid Ah examining according to claim 6, for the synthetic method of amine, is characterized in that: silylation reagent is TMSCl, TESCl, TBDMSCl, TIPSCl, TBDPSCl, TBSOTf or TBSOTCl.
8. hydrochloric acid Ah examining according to claim 6, for the synthetic method of amine, is characterized in that: acylting agent is diacetyl oxide, Benzoyl chloride, benzoyl peroxide or pivaloyl chloride.
9. hydrochloric acid Ah examining according to claim 3, for the synthetic method of amine, is characterized in that: step 2) in, formula (2) compound reacts the formula that obtains (3) compound in DMF at sulfur oxychloride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410024859.6A CN103709191A (en) | 2014-01-20 | 2014-01-20 | Synthetic method of acotiamide hydrochloride hydrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410024859.6A CN103709191A (en) | 2014-01-20 | 2014-01-20 | Synthetic method of acotiamide hydrochloride hydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103709191A true CN103709191A (en) | 2014-04-09 |
Family
ID=50402579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410024859.6A Pending CN103709191A (en) | 2014-01-20 | 2014-01-20 | Synthetic method of acotiamide hydrochloride hydrate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103709191A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103980226A (en) * | 2014-05-10 | 2014-08-13 | 杭州新博思生物医药有限公司 | Acotiamide hydrochloride hydrate crystal form and preparation method thereof |
| CN104031001A (en) * | 2014-06-30 | 2014-09-10 | 山东诚创医药技术开发有限公司 | Method for preparing 2-(N-(2,4,5-trimothoxyaniline) amino]-4-carbethoxy-1,3-thiazole by using one-pot process |
| CN104045606A (en) * | 2014-07-11 | 2014-09-17 | 杭州新博思生物医药有限公司 | One-pot method for preparing acotiamide hydrochloride |
| CN107235928A (en) * | 2017-07-11 | 2017-10-10 | 湖南七纬科技有限公司 | It is a kind of to treat medical compounds of functional dyspepsia FD and preparation method thereof |
| CN108358867A (en) * | 2018-05-05 | 2018-08-03 | 邳州易萨新型材料有限公司 | A kind of synthetic method of acotiamide hydrochloride hydrate |
| CN105753810B (en) * | 2016-04-15 | 2018-09-28 | 浙江新赛科药业有限公司 | The refined and preparation method of acotiamide hydrochloride hydrate trihydrate |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103665023A (en) * | 2013-12-23 | 2014-03-26 | 华润赛科药业有限责任公司 | Synthetic method of acotiamide hydrochloride |
-
2014
- 2014-01-20 CN CN201410024859.6A patent/CN103709191A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103665023A (en) * | 2013-12-23 | 2014-03-26 | 华润赛科药业有限责任公司 | Synthetic method of acotiamide hydrochloride |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103980226A (en) * | 2014-05-10 | 2014-08-13 | 杭州新博思生物医药有限公司 | Acotiamide hydrochloride hydrate crystal form and preparation method thereof |
| CN104031001A (en) * | 2014-06-30 | 2014-09-10 | 山东诚创医药技术开发有限公司 | Method for preparing 2-(N-(2,4,5-trimothoxyaniline) amino]-4-carbethoxy-1,3-thiazole by using one-pot process |
| CN104031001B (en) * | 2014-06-30 | 2015-09-30 | 山东诚创医药技术开发有限公司 | Cook different foods in one pot and prepare the method for 2-[N-(2,4,5-trimethoxy-benzene methylamino) is amino]-4-ethoxycarbonyl-1,3-thiazoles |
| CN104045606A (en) * | 2014-07-11 | 2014-09-17 | 杭州新博思生物医药有限公司 | One-pot method for preparing acotiamide hydrochloride |
| CN104045606B (en) * | 2014-07-11 | 2015-09-30 | 杭州新博思生物医药有限公司 | One kettle way prepares the method for Ah examining for amine hydrochlorate |
| CN105753810B (en) * | 2016-04-15 | 2018-09-28 | 浙江新赛科药业有限公司 | The refined and preparation method of acotiamide hydrochloride hydrate trihydrate |
| CN107235928A (en) * | 2017-07-11 | 2017-10-10 | 湖南七纬科技有限公司 | It is a kind of to treat medical compounds of functional dyspepsia FD and preparation method thereof |
| CN108358867A (en) * | 2018-05-05 | 2018-08-03 | 邳州易萨新型材料有限公司 | A kind of synthetic method of acotiamide hydrochloride hydrate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103709191A (en) | Synthetic method of acotiamide hydrochloride hydrate | |
| CN103709120B (en) | A kind of preparation method of acotiamide hydrochloride trihydrate | |
| CN103665023A (en) | Synthetic method of acotiamide hydrochloride | |
| CN100537541C (en) | Improved process for preparing rebamipide | |
| CN106256824B (en) | Preparation method of high-purity delafloxacin meglumine salt | |
| WO2016181414A1 (en) | Process for the synthesis of ivacaftor and related compounds | |
| JP2013541592A5 (en) | ||
| CN102471273B (en) | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof | |
| WO2023279773A1 (en) | Efficient preparation method for tedizolid intermediate, and intermediate | |
| CN104193765B (en) | A kind of synthetic method of cefixime | |
| CN102898418B (en) | Preparation method of esomeprazole magnesium | |
| CN102617498B (en) | Valsartan preparation method | |
| CN102924350B (en) | Pleuromutilin derivatives, and preparation method and application thereof | |
| WO2009064084A2 (en) | Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts | |
| JP4478140B2 (en) | Preparation of carbostyril compounds for pharmaceutical use | |
| CN102617487B (en) | Multi-substituted pyrimidinones compounds as well as preparation method and application thereof | |
| ES2710312T3 (en) | A procedure for the preparation of montelukast sodium | |
| CZ2004997A3 (en) | Novel form of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine | |
| WO2012037764A1 (en) | Method for preparing (e)-methyl 2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate | |
| ES2528188T3 (en) | Method to prepare calcium zofenopril | |
| CN102382124A (en) | Ceftizoxime alapivoxil synthesized from cephalosporin drug intermediate and preparation method thereof | |
| CA2881958C (en) | Pharmaceutical formulations containing 3-(4-cinnamyl-1-piperazinyl) amino derivatives of 3-formylrifamycin sv and 3-formylrifamycin s and a process of their preparation | |
| CN102617390B (en) | Preparation method of epsilon-N-lauroyl lysine | |
| CN104418848A (en) | Preparation method of rivaroxaban | |
| CN103508975A (en) | Preparation method of pramipexole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140409 |